PROKIDNEY CORP.
PROK · Biological Products, (No Diagnostic Substances) · 61.5M shares · EDGAR filings ↗
Net buyback after stock comp: -$21M (gross $9M, SBC $31M)
Reference price $2.37 · est. market cap ~$146M — last insider sale, 2025-11-13 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D44Clinical/early-stage biotech — renal cell-therapy clinical (rilparencel), heavy burn ($135M), very well-funded.
Strengths
- Liquidity — current ratio 9.1 (80th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- No interest coverageInterest coverage -41251.75 (cannot cover interest)
- Cash burnNegative free cash flow (-135.3M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Notable holderHeld by 5 notable fund(s): RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC +2 more (as of 2026-03-31)
Key metrics
Return on equity
6.8%
Return on assets
-20.6%
Interest coverage
-41251.8×
Current ratio
9.1×
Free cash flow
-$135M
EBITDA
-$158M
Tangible book value
-$1.0B
Cash & investments
$109M
Cash runway
3q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-12 | Girolamo Todd C | Conversion | 164K | — |
| 2026-04-28 | Control Empresarial de Capitales S.A. de C.V. | Conversion | 63.1M | — |
| 2025-11-13 | Pereira Brian JG | Sell | 54K | $2.37 |
| 2025-11-13 | Pereira Brian JG | Sell | 448K | $2.37 |
| 2025-11-12 | Pereira Brian JG | Sell | 227K | $2.72 |
| 2025-11-12 | Pereira Brian JG | Sell | 28K | $2.72 |
| 2025-07-08 | Weber Darin J. | Sell | 103K | $3.02 |
| 2025-06-03 | Legorreta Pablo G. | Conversion | 3.8M | — |
| 2025-06-03 | Legorreta Pablo G. | Other | 3.8M | — |
| 2025-04-22 | Control Empresarial de Capitales S.A. de C.V. | Buy | 387K | $0.71 |
| 2025-04-17 | Control Empresarial de Capitales S.A. de C.V. | Buy | 25K | $0.75 |
| 2025-04-16 | Control Empresarial de Capitales S.A. de C.V. | Buy | 100K | $0.75 |
| 2025-04-15 | Control Empresarial de Capitales S.A. de C.V. | Buy | 468K | $0.70 |
| 2025-04-14 | Control Empresarial de Capitales S.A. de C.V. | Buy | 268K | $0.73 |
| 2025-04-11 | Control Empresarial de Capitales S.A. de C.V. | Buy | 1.9K | $0.61 |
| 2025-04-10 | Control Empresarial de Capitales S.A. de C.V. | Buy | 1.0M | $0.61 |
| 2025-02-04 | Legorreta Pablo G. | Conversion | 533K | — |
| 2025-02-04 | Legorreta Pablo G. | Other | 533K | — |
| 2025-02-04 | Pereira Brian JG | Conversion | 82K | — |
| 2025-02-04 | Pereira Brian JG | Conversion | 675K | — |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-29 | 2026-05-28 | 0001193125-26-248210 ↗ |
| 10-Q | 2026-05-15 | 2026-03-31 | 0001193125-26-225841 ↗ |
| 8-K | 2026-05-15 | 2026-05-15 | 0001193125-26-225848 ↗ |
| 10-K | 2026-03-18 | 2025-12-31 | 0001193125-26-113881 ↗ |
| 8-K | 2026-03-18 | 2026-03-18 | 0001193125-26-113893 ↗ |
| 8-K | 2026-02-02 | 2026-02-02 | 0001193125-26-033594 ↗ |
| 8-K | 2026-01-12 | 2026-01-12 | 0001193125-26-009807 ↗ |
| 8-K | 2025-11-10 | 2025-11-10 | 0001193125-25-274314 ↗ |
| 10-Q | 2025-11-10 | 2025-09-30 | 0001193125-25-274303 ↗ |
| 8-K | 2025-10-17 | 2025-10-17 | 0001193125-25-242565 ↗ |
| 10-Q | 2025-08-12 | 2025-06-30 | 0000950170-25-107352 ↗ |
| 8-K | 2025-08-12 | 2025-08-12 | 0000950170-25-107357 ↗ |